New medical school curricula prioritize pain treatment modalities that include physical therapy, massage and acupuncture, and psychological therapies. Pain is the single most frequent reason for ...

Overdose is a risk in the management of chronic pain with opioids in primary care. Because clinicians are on the front lines in the care of patients with chronic pain in rural and remote areas, it is ...

For the first time in two decades, the FDA has approved a new class of non-opioid pain medication, offering an alternative to addictive opioids for patients seeking pain relief. The drug, suzetrigine, ...

Addressing the Opioid epidemic using multi-modal pain management strategies There is no single solution to America’s opioid crisis. With more than 90 Americans dying each day from opioid overdoses, ...

PITTSBURGH (KDKA) — For the first time in western Pennsylvania and possibly in the nation, patients at a local hospital can choose not to be given opioids before, during and after surgeries. Inside ...

Re: “As a doctor, I want patients, especially elderly ones, to have access to non-opioid drugs,” by Dr. Wes Ely, April 22 (online) and June 2 (print). I read with some concern Dr. Wes Ely's opinion ...

Envision Physician Services’ National Education Director of Anesthesiology Adam Blomberg, MD, FASA, spoke to Becker’s ASC Review about enhanced recovery after surgery protocols, opioids and the future ...

Rutgers has granted Tonix Pharmaceutical exclusive worldwide rights to develop and commercialize a novel class of compounds ...

A118G (43AA, 19AG, 18GG) 80 Taiwan females following abdominal hysterectomy GG had significantly higher postoperative day 1 morphine requirements [104] A118G Caucasians: 66 = AA, 29AG; Africans: 1 = ...

The number of community-based organizations providing naloxone kits to individuals is increasing. Nonetheless, in 2013, there were 20 states that did not have an organization providing naloxone kits ...

Add Yahoo as a preferred source to see more of our stories on Google. For the first time in two decades, the FDA has approved a new class of non-opioid pain medication, offering an alternative to ...